Synerga Fund Spolka Akcyjna Logo

Synerga Fund Spolka Akcyjna

Commercializes medical therapies globally using industrial property and copyrights for clinical use.

SNG | WAR

Overview

Corporate Details

ISIN(s):
PLMWTNS00010 (+1 more)
LEI:
259400FUSQOKWI6AY207
Country:
Poland
Address:
Kraków Grzegórzecka 67D/26, 31-559 Kraków
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Synerga.fund S.A. is a Polish company whose activities include the commercialization of medical therapies. The company's core operations focus on utilizing industrial property and copyrights to implement therapies in commercial clinical treatment. Key responsibilities involve the global marketing and scaling of these therapies, centered around building the international ONGENO brand. While its primary focus appears to be in the medical sector, some sources have also indicated the company's involvement in the financial sector, particularly with blockchain technology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Synerga Fund Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Synerga Fund Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Developing novel cancer immunotherapies, including peptide vaccines and iPS-NKT cell therapies.
Japan 4594
Brilliant Future AB Logo
A data-driven survey platform to measure and improve employee & customer experiences.
Sweden BRILL
b-style holdings,Inc. Logo
Offers flexible staffing for homemakers and specialized recruitment for skilled professionals.
Japan 302A
BTS Group Logo
Helps organizations execute strategy via experiential learning for leadership and sales teams.
Sweden BTS
B.U Technology Logo
Commercializes university research via IP management, licensing, and new venture creation.
South Korea 230980
Advancing high-grade copper and precious metal projects from discovery to production.
Canada N/A
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland CTX
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan 6070
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan 4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.